4//SEC Filing
Burke Steven Keith 4
Accession 0001562180-22-004031
CIK 0001517022other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:08 PM ET
Size
7.4 KB
Accession
0001562180-22-004031
Insider Transaction Report
Form 4
Burke Steven Keith
SVP, Chief Medical Officer
Transactions
- Award
Common Stock
2022-05-12+200,000→ 417,663 total - Award
Stock Option (Right to buy)
2022-05-12+200,000→ 200,000 totalExercise: $0.41From: 2023-05-12Exp: 2032-05-12→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The restricted stock units will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date.
- [F2]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest in full on the first anniversary of the grant date, subject to the reporting person's continued service with the Issuer on such vesting date.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeother
Related Parties
1- filerCIK 0001619834
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:08 PM ET
- Size
- 7.4 KB